605116 Stock Overview
Engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API’s), and formulations catering to the pharmaceutical market worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Aurisco Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥21.12 |
| 52 Week High | CN¥26.99 |
| 52 Week Low | CN¥17.33 |
| Beta | -0.17 |
| 11 Month Change | -10.81% |
| 3 Month Change | -5.21% |
| 1 Year Change | -16.29% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -17.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| 605116 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.6% | -1.5% | -2.1% |
| 1Y | -16.3% | -9.4% | 2.8% |
Return vs Industry: 605116 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 605116 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 605116 volatility | |
|---|---|
| 605116 Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 605116 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 605116's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,521 | Dingjun Chu | www.aurisco.com |
Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API’s), and formulations catering to the pharmaceutical market worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs.
Aurisco Pharmaceutical Co.,Ltd. Fundamentals Summary
| 605116 fundamental statistics | |
|---|---|
| Market cap | CN¥8.58b |
| Earnings (TTM) | CN¥340.67m |
| Revenue (TTM) | CN¥1.43b |
25.2x
P/E Ratio6.0x
P/S RatioIs 605116 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605116 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.43b |
| Cost of Revenue | CN¥609.64m |
| Gross Profit | CN¥818.68m |
| Other Expenses | CN¥478.02m |
| Earnings | CN¥340.67m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.84 |
| Gross Margin | 57.32% |
| Net Profit Margin | 23.85% |
| Debt/Equity Ratio | 37.4% |
How did 605116 perform over the long term?
See historical performance and comparison